Introduction
Rigidity and Multifocal Seizure Syndrome, Lethal Neonatal (RMFSL) (OMIM# 614498) is a recently defined autosomal-recessive epileptic encephalopathy, which is characterized by drug-resistant seizures, and rigidity (1, 2) . This syndrome is thought to be caused by mutations in BRAT1 (Breast Cancer 1-associated ataxia telangiectasia mutated activation-1 protein) gene (1) (2) (3) . In the literature, to the best of our knowledge, there are only three case reports suggesting a relation between this syndrome and a homozygous mutation in BRAT1 gene. These cases were reported in the Amish society, a Mexican family, and an Arabic family. Similar to each other these cases with RMFSL diagnosis and a homozygous mutation in BRAT1 gene were reported to have drug-resistant seizures, axial and extremity rigidity and delay in the increase of head circumference in the early days after birth. Additionally the death of the subjects in the first six months of the life were also reported (1) (2) (3) . This case, diagnosed as RMFSL with a homozygous mutation in BRAT1 gene, is the fourth one in the
A C C E P T E D M A N U S C R I P T

ACCEPTED MANUSCRIPT
literature and the first one being reported from a Turkish family. Besides, in this case a new mutation, not reported earlier, was found to be involved .
Case Report
A 27-day old baby born of a consanguineous marriage in a Turkish family was admitted to our center from another hospital because of drug resistant myoclonic seizures. He had no EEG monitoring before admission to our hospital. The patient history revealed occurrence of respiratory distress immediately after birth and drug-resistant seizures despite treatment with phenytoin, phenobarbital, and midazolam. The baby was receiving medical care in a neonatal intensive care unit (NICU) since birth. He was a male twin, and the mother reported abnormal movements of him with respect to her female baby in the late weeks of the pregnancy. The birth was a cesarean-section. Apgar scores in the first and fifth minutes were 8/8, birth weight was 2200 g (10-25%), head circumference was 30 cm (<10%) and the height was 43.5 cm (10-25%). The weight at evaluation in our center was 2320 g, the height was 45 cm and the head circumference was 31 cm. Anterior fontanelle was open and sized 1×1 cm. The baby, in response to touch, showed myoclonic seizures in the extremities and face. He had hypertonia and resistance during extension in his arms. He did not have a dysmorphic face; his deep tendon reflexes were hyperactive and had four to five beats of clonus. He had difficulty in swallowing, needed aspiration frequently and was started to be fed by orogastric tube. BRAT1 protein is consisted of 821 aminoacids and this mutation causes defect from the 747 th aminoacid and leads to the cessation of the protein synthesis 36 aminoacids later. These findings confirmed RMFSL. In addition, mother and father were also found to be heterozygous for the same mutation. Genetic testing was not performed in the sibling since she had no clinical findings and she was fraternal twin. When the child was 5 months old she was still intubated and feeding with orogastric catheter so that tracheostomy and gastrostomy were performed and after that she was transferred to a pediatric intensive care unit (PICU).
The seizures and involuntary movements increased by impulses and the rigidity has persisted till the tenth month. He had dropping head circumference percentiles (< 3%) and neurological motor delay. The patient was lost because of multiorgan failure at the age of 10 months.
Discussion
RMFSL was first reported in three newborns from three relative families in the Amish Society . However, cranial MR taken at the fourth month showed changes in the brain in compliance with atrophy. This finding indicates that RMSFL causes progressive changes in the brain and even if brain imaging is normal initially, pathologic changes may appear in the upcoming period.
As far as we know in the literature, there are only three case reports of a homozygous mutation in the BRAT1 gene (1-3). Furthermore, three case reports with clinical similarity to RMSFL and with a heterozygous mutation in the BRAT1 gene were also published (4-6).
One of these reports was about two brothers with hypertonicity, drug-resistant seizures, apneic episodes, dysmorphic face, cerebral and cerebellar atrophy in brain imaging and the subjects died at the 3rd and 12th months (4) . The other two case reports with a heterozygous mutation in the BRAT1 gene had milder clinical courses than classical RMSFL. They were reported to be 4 and 6 years old and still alive (5, 6) . It can be asserted, from the previous reports that homozygous mutation in BRAT1 gene possibly causes more severe clinical findings and shorter life expectancy than heterozygous mutation.
Interestingly, frameshift mutations have frequently been detected in RMSFL cases (1) (2) (3) (4) (5) (6) . A frameshift mutation was also detected in our case. The distribution of the mutations suggests that the mutations that affect the end parts of the proteins have the major role in the pathogenesis of the disaese. The mutation, s747tfs*36, which we detected, involves largest number of codons. And it shows that a frameshift mutations that affect the aminoacids between 747 and 821 may cause RMFSL.
In conclusion, RMSFL should be considered in the differential diagnosis in the evaluation of newborns with drug-resistant seizures and rigidity; and BRAT1 gene mutation should be investigated in suspected cases.
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